Drug conjugate - CyGenica
Latest Information Update: 29 Sep 2023
At a glance
- Originator CyGenica
- Class Antineoplastics; Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Glioblastoma
Highest Development Phases
- Research Glioblastoma